PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

A Study of AMG 820 in Subjects With Advanced Solid Tumors

A Study of AMG 820 in Subjects With Advanced Solid Tumors


Basic Trial Information

Protocol Phase:Phase I
Study Category:Biomarker/Laboratory analysis
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary ID20060347
Other IDNCT01444404
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: